World Vaccine Manufacturing Congress - Sponsor list

GE Healthcare is a $16-billion unit of the General Electric Company (NYSE:GE), employing more than 46,000 people worldwide. Our healthymagination program to address global healthcare needs and to make health sustainable, aims to help our customers provide healthcare at a lower cost, to more people, with improved quality. GE Healthcare Life Sciences supports customers with advanced technologies...

Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D...

CSL Biotherapies understands the influenza vaccine business and customers’ needs for reliable and safe flu vaccine supplies. Our long-established parent , CSL Limited , has been producing flu vaccines without disruption for more than four decades . Based in Melbourne, Australia , CSL provides flu vaccines to Australia, New Zealand , United States of America and more than 16 countries in Europe ...

Esoterix Clinical Trials Services is a full service Central Laboratory for clinical development driving R&D productivity by focusing its suite of technologies and services on helping PharmaBio clients to expedite new products to market. We combine standardized international laboratory capabilities with sophisticated diagnostic technologies to provide a broad portfolio of clinical assays in...

Encorium is a full service CRO with experience in more than 30 countries worldwide. With expertise and investigator networks we have serviced successfully over 20 clients and recruited over 55,000 subjects/patients in pediatric, adult and elderly populations for prophylactic and therapeutic vaccine. By establishing a global CRO network Encorium is strengthening its offerings in vaccine...

Medicago is committed to provide highly effective and affordable vaccines based on proprietary VLPs and manufacturing technologies. Medicago is developing VLP vaccines to protect against influenza, using a transient expression system producing recombinant antigens in non-transgenic plants. This technology has potential to offer speed and cost advantages over competitive technologies. It could...

RPS, The Next Generation CRO, provides comprehensive global Phase I-IV clinical development solutions to the pharmaceutical, biotechnology and medical device industries. By combining an experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Clients a broad spectrum of outsourcing solutions. These solutions...

Delphi Genetics focuses on developing effective technologies using bacterial poison-antidote genes for the production of recombinant vaccines in E. coli. The patented Staby Express technology improves the yield of recombinant antigen and this without the use of antibiotics, this technology has been licensed to Sanofi-Pasteur and GSK.

West Pharmaceutical Services, Inc. is a global leader in providing solutions for injectable drug administration. The products West makes and the services the company provides help improve health care for people around the globe. West’s innovative system, device and component solutions help improve the safety and administration of injectable drugs. West’s proprietary materials...

Isconova AB is a leading international vaccine adjuvant company. Isconova has vast knowledge of vaccine systems and the company develops vaccines together with partners in the human and veterinary markets. The first vaccine using Isconovas technology was launched on the veterinary market in 2005. In the human market several vaccines are under development with Isconova’s nano-particle, Matrix...

University of Tampere Vaccine Research Center is a well established organization for clinical trials of vaccines, with 20 years of experience and 12 vaccine study clinics in Finland. The spectrum of studies ranges from phase I to phase IV, and from infants to elderly. Specific achievements include pivotal trials for licensure of rotavirus vaccines and, more recently, improved influenza vaccines...

Crucell N.V. is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. In 2010 alone, Crucell distributed more than 105 million vaccine doses in more than 100 countries around the world. Crucell is one of the major suppliers of vaccines to UNICEF and the developing...

Immune Targeting Systems (ITS) Limited is developing synthetic vaccines for mutating viruses. The Company's enabling T-cell vaccine platform enables it to target highly conserved parts of the virus ("antigens") and direct an T-cell immune response to those cells in the body infected with one of these difficult viruses. The fluoropeptide vaccine technology then delivers these antigens into the...

Cilian AG is an innovative biotechnology company, which uses the singular abilities of Ciliates, a class of production micro-organisms, for the production of therapeutic proteins. By the direct application of these impressing abilities of Ciliates the company has established an expression system and plans to produce therapeutic proteins extremely economically. Cilian AG is therefore actively...

CONFARMA is a CRO since 1972, specialized in R & D, CMC and studies. Activities : Analytical chemistry, Galenics, Stability studies, Microbiology, Biochemistry, Biology, Immunology, Molecular Biology, Pharmacology-Toxicology Phases of development : R & D (contract research), Preclinical, Clinical (only analytics), Commercial (CMC) Markets : Academical Research Institutions, EU collaborative...

Eurogentec Biologics offers GMP contract manufacturing of proteins, plasmids, bacterial vaccines and conjugates for clinical trial and commercial supply. We are a full service CMO, offering in house development of USP, DSP, QC’s, and manufacturing of GMP cell banks, GMP clinical trial material and QP release of DS and DP. Learn more at www.eurogentec.com

Vivalis provides cell-based technologies for the production of human therapeutics based on recombinant viruses, monoclonal antibodies, and non-antibody proteins. Our EB66(r) cell line has been licensed to over 25 companies for the production of novel biologics. We also offer contract manufacturing services with a special emphasis on the production of MVA-based vectors.

PX’Therapeutics, located in Grenoble and Lyon (France), is dedicated to the development of therapeutic proteins, antibodies and recombinant vaccines from early stage research and up to GMP manufacturing. PX’Therapeutics proposes custom programs, ranging from protein engineering, murine antibody generation, antibody humanization/chimerization, to the development or optimization of production...

Vibalogics supports innovative companies which are developing vaccines, gene therapeutics or virotherapeutics. We work with live viruses and bacteria and offer process development, GMP-manufacturing, analytical testing and fill & finish. In addition we generate and select expression vectors based on Pichia pastoris, one of the most promising expression hosts for vaccines based on virus-like...

One of the world's leaders in contract manufacturing of microbial vaccines, recombinant proteins and plasmids for clinical trial and commercial manufacturing. Come visit our stand for more information.

STERIS Life Sciences provide infection and contamination control solutions to the Global Pharma and Biopharma industry sectors. We provide validatable cleaning agents and antimicrobial products in addition to sterility assurance products (biological and chemical indicators) for various sterilisation processes. Additionally, we offer GMP and non-GMP capital equipment associated with...

Vibalogics supports innovative companies which are developing vaccines, gene therapeutics or virotherapeutics. We work with live viruses and bacteria and offer process development, GMP-manufacturing, analytical testing and fill & finish. In addition we generate and select expression vectors based on Pichia pastoris, one of the most promising expression hosts for vaccines based on virus-like...

ViroClinics Biosciences is a contract research organization providing an array of services to the biopharmaceutical industry including diagnostic testing and preclinical services, contract research and general consultancy to accelerate the development of vaccines, antivirals and in vitro diagnostics. Furthermore, Viroclinics Biosciences has a number of research programs aimed at identifying new...

University of Tampere Vaccine Research Center is a well established organization for clinical trials of vaccines, with 20 years of experience and 12 vaccine study clinics in Finland. The spectrum of studies ranges from phase I to phase IV, and from infants to elderly. Specific achievements include pivotal trials for licensure of rotavirus vaccines and, more recently, improved influenza vaccines...